サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451711

トランスクリプトミクス市場レポート：タイプ、技術、用途、エンドユーザー、地域別、2024-2032

Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.84円
トランスクリプトミクス市場レポート：タイプ、技術、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のトランスクリプトミクス市場規模は2023年に72億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに118億米ドルに達し、2024年から2032年の間に5.44%の成長率（CAGR）を示すと予測しています。

トランスクリプトミクスは、特定の時間、条件、細胞において、あらゆる生物の遺伝子型によって産生されるリボ核酸（RNA）転写物の分析です。ゲノム、プロテオーム、細胞表現型を結びつける。トランスクリプトミクスは、RNAの転写や発現レベル、機能、位置、輸送、分解など、RNAに関連するすべてを網羅します。トランスクリプトミクスは、遺伝子の転写構造を決定するために、マイクロアレイ解析、リアルタイム定量ポリメラーゼ連鎖反応（Q-PCR）、シークエンシング技術を利用します。また、転写活性の特徴を明らかにし、関連する標的遺伝子や転写産物のサブセットに焦点を当て、生物・生物学的環境ストレスに応答・対抗する遺伝子や経路を特定する上で研究者を支援します。

トランスクリプトミクス市場の動向：

世界中で個別化医療への需要が高まっていることが、市場に明るい展望をもたらしています。トランスクリプトミクスは、PCRアプリケーションの増加や、RNAシーケンスの広範な使用など、この分野の改良により広く使用されています。これに伴い、遺伝情報を得るための研究用途におけるRNAシーケンスの需要の高まりも、市場の成長を後押ししています。RNAシーケンシングはトランスクリプトーム解析を完全に変革し、1回の調査で遺伝子発現レベルの定量化、新規遺伝子、スプライスアイソフォーム、融合転写産物の親和性、非コードRNAの世界への並外れた研究を可能にしました。これとは別に、主なプレーヤーは、病気や診断における新しい機器や技術の開発に絶えず注力しており、これが市場の成長を増強しています。さらに、詳細なRNAシーケンス分析を提供できる全トランスクリプトームシーケンス（WTS）を備えた先進的な遺伝子プロファイリング製品の発売は、市場成長にプラスの影響を与えています。このほか、広範な研究開発（R&D）活動、COVID-19病の発生によるトランスクリプトミクス需要の増加、さまざまな政府イニシアチブの実施とオミックスへの資金提供が市場成長を支えています。

本レポートで扱う主な質問

  • 2023年の世界トランスクリプトミクス市場規模は？
  • 2024-2032年の世界トランスクリプトミクス市場の予想成長率は？
  • 世界のトランスクリプトミクス市場を牽引する主要因は何か？
  • COVID-19が世界のトランスクリプトミクス市場に与えた影響は？
  • トランスクリプトミクスの世界市場のタイプ別区分は？
  • 技術別世界トランスクリプトミクス市場の内訳は？
  • トランスクリプトミクスの世界市場の用途別区分は？
  • 世界トランスクリプトミクス市場の主要地域は？
  • トランスクリプトミクスの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のトランスクリプトミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 機器
    • 市場動向
    • 市場予測
  • 消耗品
    • 市場動向
    • 市場予測
  • ソフトウェア
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • マイクロアレイ
    • 市場動向
    • 市場予測
  • リアルタイム定量ポリメラーゼ連鎖反応（Q-PCR）
    • 市場動向
    • 市場予測
  • シーケンス技術
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 診断と疾患プロファイリング
    • 市場動向
    • 市場予測
  • 創薬
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 学術・研究機関
    • 市場動向
    • 市場予測
  • 製薬企業
    • 市場動向
    • 市場予測
  • バイオ関連企業
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • Biospyder Technologies Inc.
    • Illumina Inc.
    • Nanostring Technologies Inc.
    • Qiagen
    • Roche Holding AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transcriptomics Market: Major Drivers and Challenges
  • Figure 2: Global: Transcriptomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transcriptomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transcriptomics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Transcriptomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Transcriptomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Transcriptomics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Transcriptomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Transcriptomics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Transcriptomics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Transcriptomics (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Transcriptomics (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Transcriptomics (Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Transcriptomics (Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Transcriptomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Transcriptomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Transcriptomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Transcriptomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Transcriptomics (Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Transcriptomics (Sequencing Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Transcriptomics (Sequencing Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Transcriptomics (Diagnostics and Disease Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Transcriptomics (Diagnostics and Disease Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Transcriptomics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Transcriptomics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Transcriptomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Transcriptomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Transcriptomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Transcriptomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Transcriptomics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Transcriptomics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Transcriptomics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Transcriptomics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Transcriptomics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Transcriptomics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Transcriptomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Transcriptomics Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Transcriptomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Transcriptomics Industry: SWOT Analysis
  • Figure 87: Global: Transcriptomics Industry: Value Chain Analysis
  • Figure 88: Global: Transcriptomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcriptomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transcriptomics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Transcriptomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Transcriptomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Transcriptomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Transcriptomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Transcriptomics Market: Competitive Structure
  • Table 8: Global: Transcriptomics Market: Key Players
目次
Product Code: SR112024A6585

The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.

Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.

Transcriptomics Market Trends:

The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.

Breakup by Type:

Instruments

Consumables

Software

Services

Breakup by Technology:

Microarray

Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)

Sequencing Technologies

Breakup by Application:

Diagnostics and Disease Profiling

Drug Discovery

Others

Breakup by End User:

Academic and Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global transcriptomics market in 2023?
  • 2. What is the expected growth rate of the global transcriptomics market during 2024-2032?
  • 3. What are the key factors driving the global transcriptomics market?
  • 4. What has been the impact of COVID-19 on the global transcriptomics market?
  • 5. What is the breakup of the global transcriptomics market based on type?
  • 6. What is the breakup of the global transcriptomics market based on the technology?
  • 7. What is the breakup of the global transcriptomics market based on the application?
  • 8. What are the key regions in the global transcriptomics market?
  • 9. Who are the key players/companies in the global transcriptomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcriptomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing Technologies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Diagnostics and Disease Profiling
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Discovery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic and Research Institutes
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 BGI Group
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biospyder Technologies Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Illumina Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nanostring Technologies Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Qiagen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Roche Holding AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Takara Bio Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.